36Kr learned that on July 15, Chongqing Yichong Technology Co., Ltd. (hereinafter referred to as "Yichong Technology") announced the completion of strategic financing of hundreds of millions of yuan. The investor is Tianjin Ruipu Biotechnology, a leader in the animal health products industry. Co., Ltd. (hereinafter referred to as "Rip Biotechnology"). This financing will be mainly used for the creation of the self-developed brand of "Yi Chong Technology", the upgrading of the supply chain, and the offline expansion of front-end business.

"Yi Pet Technology" was founded in 2008. It is a group company that provides omni-channel operation and management services for pet brands. It owns the industry-renowned pet product consumption and selection platform - Epet Mall, the pet store empowerment platform - Tapin, the online operation and management platform for domestic and overseas brands - Hangzhou Yipiao, as well as the famous brands such as Xiaoqingsha, Qiaowei, The matrix of popular self-developed brands represented by Zero Gray. At the same time, "Easy Pet Technology" has established cooperative relationships with more than 1,300 pet brands and more than 30,000 pet stores at home and abroad. It has served more than 4 million pet-raising families and is committed to Provide high-quality products and services throughout the life cycle for Chinese pet-raising families.

"Rip Biotechnology" (stock code: 300119) was established in 1998. It is a company integrating the research and development, production and sales of animal vaccines, pharmaceutical preparations, APIs and functional additives. It is a leading animal protection enterprise with 14 subsidiaries. According to the "2020 Animal Health Industry Ranking" released by Animal Pharm, the world's authoritative organization for animal health, Rip Biotech ranks first among global animal health companies with a revenue growth rate (229.2%) in the past five years. In 2021, Rip Biotech was ranked first by the International The authoritative research and consulting organization IHS Markit rated it as "The Best Animal Health Company in Asia, Australia, and Africa" ​​(4 companies in the world, one company each in Europe, North America, South America, and Asia). In 2015, "Rip Bio" entered the pet medical field and invested in Rip Pai Pet Hospital.

"Ruipai Pet Hospital" was established in 2012 and is an influential pet medical chain institution in China. The founder is Dr. Li Shoujun, an expert who enjoys special subsidies from the State Council. As a leading company in China's pet medical industry, Ruipai is led by domestic first-class experts and technical teams such as Dong Yuenong and Xie Fuqiang, and has brought together more than 1,600 top experts, physicians, and assistant physicians in the industry to provide standardized and professional management. The system operates in more than 20 provinces (municipalities) and nearly 500 hospitals in more than 50 cities across the country. At present, Ruipai's investors include China's A-share listed company Ruipu Biologics, as well as Goldman Sachs Capital, Huatai Industrial Fund, Yuexiu Financial Holdings, Ruiji Biological Fund, Mars Group, etc., with a valuation of more than 12 billion yuan.

Based on the development stage and future trends of the pet industry, "Yi Chong Technology", "Rip Biotech" and "Rip Pai Pet Hospital" have signed a strategic cooperation agreement out of long-term win-win considerations. The parties will Establishing in-depth strategic cooperation relationships in the fields of supply chain, channel integration, digitalization, pet medical care, etc. will help realize their respective long-term development aspirations in building a pet industry ecosystem and extending the pet life quality service chain.

With this strategic investment, "Ripai Biotech" can use the channels of "Yichong Technology" to promote its own products and services; for "Ripai Pet Hospital", through By cooperating with "Yi Chong Technology", we can establish and open up a powerful drug supply chain of the Ruipai pet medical system, and provide more high-quality products and services for pets. For "Yi Pet Technology", the most direct benefit is the increase in revenue channels: "Ruipai Pet Hospital" has more than 500 mid-to-high-end pet hospitals, and the marketing level can directly drive the sales revenue of "Yi Pet Technology".

On the other hand, establishing a strategic cooperative relationship with "Rip Biotechnology" and "Ripai Pet Hospital" is related to improving the "Yi Pet Technology" industrial service chain and can help "Yi Pet Technology" Pet Technology" realizes the resource integration layout of the industrial chain.

The pet economy is mainly divided into three categories: services, food and medical care. "Yichong Technology" started with pet food rations. Five years ago, it began to deploy the B-side and established a professional pet store service platform "Taipin". "Taipin" is mainly responsible for linking pet stores. Regardless of online or offline stores, it can provide pet store operators with professional support such as genuine supply, store marketing, and personnel training. As the business continues to deepen and consumption patterns continue to become more complex and diversified, the original channel models represented by "E-pet Mall", "Taipin", and "Hangzhou Yi-pet" are also constantly transforming and upgrading. "Yi-pet Technology" It no longer just focuses on the paradigm operation of large centers and large traffic, but continues to increase personalized investment in the decentralized small B system based on the premise of respecting consumption patterns and industry trends. With the help of Ruipai, the platform system and small B system linked to "Yi Pet Technology" will open up medicines and medical services on the basis of the supply of pet food and supplies, so as to extend the overall service chain.

The person in charge of "Yi Chong Technology" said, "This strategic financing is not only a strong alliance, but also an interaction of complex industrial resources, which is good news for the pet consumer industry. "Leveraging the advantages of all parties and sharing results to achieve the purpose of industrial resource integration, all parties will carry out all-round cooperation in products, pet medical systems, technological innovation, supply chain finance and other aspects in the future.

The person in charge of "Ruipai Biology" and "Ruipai Pet Hospital" said, "Whether it is in the 2C field or the 2B field, Yichong is a leading enterprise in the industry. They have always adhered to and practiced the pet industry values ​​​​, and is also very consistent with Ruipu’s industrial investment philosophy. I believe that in the future development, Yi Chong will also occupy an important position in the entire pet industry ecology.”